RS50370B - N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi - Google Patents
N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensiInfo
- Publication number
- RS50370B RS50370B YUP-670/02A YUP67002A RS50370B RS 50370 B RS50370 B RS 50370B YU P67002 A YUP67002 A YU P67002A RS 50370 B RS50370 B RS 50370B
- Authority
- RS
- Serbia
- Prior art keywords
- group
- amino
- alkyl
- carbonyl
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MEP-174/08A MEP17408A (en) | 2000-03-23 | 2001-03-22 | N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0003724A FR2806722B1 (fr) | 2000-03-23 | 2000-03-23 | Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU67002A YU67002A (sh) | 2005-07-19 |
| RS50370B true RS50370B (sr) | 2009-11-10 |
Family
ID=8848428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YUP-670/02A RS50370B (sr) | 2000-03-23 | 2001-03-22 | N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6680329B2 (https=) |
| EP (1) | EP1268469B1 (https=) |
| JP (1) | JP2003528098A (https=) |
| KR (1) | KR100791693B1 (https=) |
| CN (1) | CN1183128C (https=) |
| AR (1) | AR029900A1 (https=) |
| AT (1) | ATE269325T1 (https=) |
| AU (2) | AU2001246617B2 (https=) |
| BG (1) | BG65863B1 (https=) |
| BR (1) | BR0109385A (https=) |
| CA (1) | CA2401637C (https=) |
| DE (1) | DE60103868T2 (https=) |
| DK (1) | DK1268469T3 (https=) |
| EA (1) | EA004986B1 (https=) |
| EE (1) | EE05084B1 (https=) |
| ES (1) | ES2222358T3 (https=) |
| FR (1) | FR2806722B1 (https=) |
| HR (1) | HRP20020762B1 (https=) |
| HU (1) | HUP0300695A2 (https=) |
| IL (2) | IL151619A0 (https=) |
| IS (1) | IS2304B (https=) |
| ME (1) | MEP17408A (https=) |
| MX (1) | MXPA02009276A (https=) |
| NO (1) | NO324835B1 (https=) |
| PL (1) | PL204660B1 (https=) |
| PT (1) | PT1268469E (https=) |
| RS (1) | RS50370B (https=) |
| SI (1) | SI1268469T1 (https=) |
| SK (1) | SK286687B6 (https=) |
| TR (1) | TR200402343T4 (https=) |
| TW (1) | TWI290141B (https=) |
| UA (1) | UA71667C2 (https=) |
| WO (1) | WO2001070736A1 (https=) |
| ZA (1) | ZA200206996B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1567497B1 (en) * | 2002-12-06 | 2009-09-23 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| US8729107B2 (en) * | 2002-12-06 | 2014-05-20 | Purdue Research Foundation | Pyridines for treating injured mammalian nerve tissue |
| WO2005102991A1 (ja) * | 2004-04-19 | 2005-11-03 | Daiso Co., Ltd. | 非天然型アミノ酸の製造方法およびその中間体 |
| US7750162B2 (en) | 2004-04-19 | 2010-07-06 | Daiso Co., Ltd. | Process for preparation of nonnatural amino acid and intermediate thereof |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| JP5492189B2 (ja) * | 2008-04-09 | 2014-05-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｃｒ１０アンタゴニストである２−スルホニルアミノ−４−ヘテロアリールブチロアミド |
| US8859814B2 (en) * | 2008-05-22 | 2014-10-14 | Boehringer Ingelheim International Gmbh | Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them |
| MX345259B (es) * | 2010-01-28 | 2017-01-23 | The Medicines Company (Leipzig) Gmbh | Inhibidores de serina proteasas similares a tripsina, y su preparación y uso. |
| FR2981071B1 (fr) * | 2011-10-10 | 2014-02-07 | Centre Nat Rech Scient | Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2727410B1 (fr) * | 1994-11-25 | 1996-12-20 | Synthelabo | Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese |
| FR2728570B1 (fr) * | 1994-12-23 | 1997-04-11 | Synthelabo | Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique |
| FR2756285B1 (fr) * | 1996-11-22 | 1998-12-18 | Synthelabo | Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique |
| FR2756220B1 (fr) * | 1996-11-27 | 1998-12-24 | Lorraine Laminage | Roue pour vehicule terrestre a moteur |
| FR2771094B1 (fr) * | 1997-11-19 | 2000-02-04 | Synthelabo | Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique |
-
2000
- 2000-03-23 FR FR0003724A patent/FR2806722B1/fr not_active Expired - Fee Related
-
2001
- 2001-03-22 ME MEP-174/08A patent/MEP17408A/xx unknown
- 2001-03-22 KR KR1020027012432A patent/KR100791693B1/ko not_active Expired - Fee Related
- 2001-03-22 EP EP01919537A patent/EP1268469B1/fr not_active Expired - Lifetime
- 2001-03-22 SI SI200130152T patent/SI1268469T1/xx unknown
- 2001-03-22 HU HU0300695A patent/HUP0300695A2/hu unknown
- 2001-03-22 EE EEP200200540A patent/EE05084B1/xx not_active IP Right Cessation
- 2001-03-22 TR TR2004/02343T patent/TR200402343T4/xx unknown
- 2001-03-22 PL PL364988A patent/PL204660B1/pl not_active IP Right Cessation
- 2001-03-22 SK SK1351-2002A patent/SK286687B6/sk not_active IP Right Cessation
- 2001-03-22 UA UA2002097272A patent/UA71667C2/uk unknown
- 2001-03-22 CN CNB018084974A patent/CN1183128C/zh not_active Expired - Fee Related
- 2001-03-22 AU AU2001246617A patent/AU2001246617B2/en not_active Ceased
- 2001-03-22 AU AU4661701A patent/AU4661701A/xx active Pending
- 2001-03-22 AR ARP010101337A patent/AR029900A1/es active IP Right Grant
- 2001-03-22 RS YUP-670/02A patent/RS50370B/sr unknown
- 2001-03-22 BR BR0109385-1A patent/BR0109385A/pt not_active Application Discontinuation
- 2001-03-22 DE DE60103868T patent/DE60103868T2/de not_active Expired - Lifetime
- 2001-03-22 ES ES01919537T patent/ES2222358T3/es not_active Expired - Lifetime
- 2001-03-22 MX MXPA02009276A patent/MXPA02009276A/es active IP Right Grant
- 2001-03-22 EA EA200200838A patent/EA004986B1/ru not_active IP Right Cessation
- 2001-03-22 AT AT01919537T patent/ATE269325T1/de active
- 2001-03-22 PT PT01919537T patent/PT1268469E/pt unknown
- 2001-03-22 TW TW090106733A patent/TWI290141B/zh active
- 2001-03-22 US US10/221,404 patent/US6680329B2/en not_active Expired - Fee Related
- 2001-03-22 DK DK01919537T patent/DK1268469T3/da active
- 2001-03-22 CA CA002401637A patent/CA2401637C/en not_active Expired - Fee Related
- 2001-03-22 HR HR20020762A patent/HRP20020762B1/xx not_active IP Right Cessation
- 2001-03-22 JP JP2001568937A patent/JP2003528098A/ja not_active Ceased
- 2001-03-22 IL IL15161901A patent/IL151619A0/xx unknown
- 2001-03-22 WO PCT/FR2001/000861 patent/WO2001070736A1/fr not_active Ceased
-
2002
- 2002-08-30 ZA ZA200206996A patent/ZA200206996B/en unknown
- 2002-08-30 IS IS6535A patent/IS2304B/is unknown
- 2002-09-04 IL IL151619A patent/IL151619A/en not_active IP Right Cessation
- 2002-09-19 NO NO20024496A patent/NO324835B1/no not_active IP Right Cessation
- 2002-09-20 BG BG107130A patent/BG65863B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102482218B (zh) | 作为蛋白激酶调节剂的吡啶和吡嗪衍生物 | |
| CN103249720B (zh) | 作为hdl-胆固醇升高剂的肟化合物 | |
| MXPA05000193A (es) | Derivados de indol utiles como antagonistas de la histamina h2. | |
| WO1999011267A1 (en) | Pyrazinone thrombin inhibitors | |
| EP1133488A1 (en) | Propanoic acid derivatives as integrin inhibitors | |
| AU2006200864A1 (en) | TNF-alpha production inhibitors | |
| EP1334098A2 (en) | Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders | |
| KR20110133049A (ko) | 항암 약물로서의 니코틴아미드 유도체, 그의 제조법 및 그의 치료 용도 | |
| RS50370B (sr) | N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi | |
| EP1663238B1 (en) | HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY | |
| CA2844834A1 (en) | 5-cycloalkyl- or 5-heterocyclyl-nicotinamides | |
| US20070099927A1 (en) | Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors | |
| US20120094986A1 (en) | Anticancer deriviatives, preparation thereof, and therapeutic use thereof | |
| CA2844865A1 (en) | 3-pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents | |
| HK1051537B (en) | N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants | |
| HK1187912B (en) | Oxime compounds as hdl-cholesterol raising agents | |
| JP2024544556A (ja) | Ｄｒａｋ２阻害剤およびその製造方法と使用 | |
| HK1193598A (en) | 5-cycloalkyl-or 5-heterocyclyl-nicotinamides | |
| HK1193599A1 (en) | N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |